###begin article-title 0
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans </italic>
###xml 0 12 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 0 23 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Cryptococcus neoformans induces IL-8 secretion and CXCL1 expression by human bronchial epithelial cells
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans </italic>
###xml 25 38 25 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 0 12 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 0 23 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 25 38 <span type="species:ncbi:5207">C. neoformans</span>
Cryptococcus neoformans (C. neoformans) is a globally distributed fungal pathogen with the potential to cause serious disease, particularly among immune compromised hosts. Exposure to this organism is believed to occur by inhalation and may result in pneumonia and/or disseminated infection of the brain as well as other organs. Little is known about the role of airway epithelial cells in cryptococcal recognition or their ability to induce an inflammatory response.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 117 126 117 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 157 171 157 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 157 170 <span type="species:ncbi:5207">C. neoformans</span>
Immortalized BEAS-2B bronchial epithelial cells and primary normal human bronchial epithelium (NHBE) were stimulated in vitro with encapsulated or acapsular C. neoformans cultivated at room temperature or 37degreesC. Activation of bronchial epithelial cells was characterized by analysis of inflammatory cytokine and chemokine expression, transcription factor activation, fungal-host cell association, and host cell damage.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 7 21 7 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 233 247 233 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 277 291 271 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 494 507 485 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 693 706 684 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 7 20 <span type="species:ncbi:5207">C. neoformans</span>
###xml 233 246 <span type="species:ncbi:5207">C. neoformans</span>
###xml 277 290 <span type="species:ncbi:5207">C. neoformans</span>
###xml 494 507 <span type="species:ncbi:5207">C. neoformans</span>
###xml 693 706 <span type="species:ncbi:5207">C. neoformans</span>
Viable C. neoformans is a strong activator of BEAS-2B cells, resulting in the production of the neutrophil chemokine Interleukin (IL)-8 in a time- and dose-dependent manner. IL-8 production was observed only in response to acapsular C. neoformans that was grown at 37degreesC. C. neoformans was also able to induce the expression of the chemokine CXCL1 and the transcription factor CAAT/enhancer-binding protein beta (CEBP/beta) in BEAS-2B cells. NHBE was highly responsive to stimulation with C. neoformans; in addition to transcriptional up regulation of CXCL1, these primary cells exhibited the greatest IL-8 secretion and cell damage in response to stimulation with an acapsular strain of C. neoformans.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 104 118 104 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 217 226 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 295 308 295 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 416 423 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 104 117 <span type="species:ncbi:5207">C. neoformans</span>
###xml 295 308 <span type="species:ncbi:5207">C. neoformans</span>
###xml 310 315 <span type="species:ncbi:9606">Human</span>
This study demonstrates that human bronchial epithelial cells mediate an acute inflammatory response to C. neoformans and are susceptible to damage by this fungal pathogen. The presence of capsular polysaccharide and in vitro fungal culture conditions modulate the host inflammatory response to C. neoformans. Human bronchial epithelial cells are likely to contribute to the initial stages of pulmonary host defense in vivo.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans </italic>
###xml 25 38 25 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 230 244 230 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 584 585 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 731 745 731 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 833 835 833 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 842 844 842 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 984 985 976 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1043 1044 1035 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1133 1134 1117 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1157 1158 1141 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1222 1235 1206 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1366 1380 1350 1364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1381 1382 1365 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1383 1385 1367 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1488 1502 1472 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1533 1535 1517 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 0 12 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 0 23 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 25 38 <span type="species:ncbi:5207">C. neoformans</span>
###xml 230 243 <span type="species:ncbi:5207">C. neoformans</span>
###xml 250 256 <span type="species:ncbi:9606">humans</span>
###xml 571 576 <span type="species:ncbi:4932">yeast</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
###xml 731 744 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1222 1235 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1366 1379 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1488 1501 <span type="species:ncbi:5207">C. neoformans</span>
Cryptococcus neoformans (C. neoformans) has been recognized as an important emerging fungal pathogen throughout the world during the past two decades [1]. Healthy individuals frequently develop asymptomatic or mild infection with C. neoformans while humans with impaired host defenses may progress to severe pneumonia and potentially fatal meningoencephalitis [2]. Natural infection is believed to occur via inhalation and is usually caused by an encapsulated cryptococcal strain, although recent investigations have reported similar clinical disease caused by acapsular yeast forms [3,4]. The use of animal models such as genetically engineered or naturally mutant mice have shown that the protective host immune response against C. neoformans requires type 1 helper T (Th1)-cell mediated immunity characterized by activation of CD4+ and CD8+ T cells and secretion of the Th1-related cytokines gamma interferon (IFN-gamma), IL-12, IL-18, and tumor necrosis factor alpha (TNF-alpha) [5]. A variety of other cell populations including B cells [6], natural killer (NK), NKT, gamma-delta antigen receptor-bearing T (gammadeltaT) cells [7] and dendritic cells [8] have also been implicated in the host immune response against C. neoformans. Furthermore, several investigations have defined a major role for lung alveolar macrophages in the initial host response against C. neoformans [9,10]. While there is little doubt that the alveolar macrophage is a key mediator of host immunity against C. neoformans and other pulmonary pathogens [11], the role of pulmonary epithelial cells in resistance to cryptococcal infection has not been well-characterized.
###end p 11
###begin p 12
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 516 530 516 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 666 668 666 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 739 748 739 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 828 842 828 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 929 931 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1043 1056 1043 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1125 1127 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1261 1275 1261 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1303 1305 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1404 1418 1404 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1661 1674 1661 1674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1812 1825 1808 1821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1853 1867 1849 1863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 2157 2171 2150 2164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 2333 2347 2326 2340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 516 529 <span type="species:ncbi:5207">C. neoformans</span>
###xml 565 570 <span type="species:ncbi:9606">human</span>
###xml 717 722 <span type="species:ncbi:4932">yeast</span>
###xml 828 841 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1043 1056 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1261 1274 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1404 1417 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1578 1583 <span type="species:ncbi:9606">human</span>
###xml 1661 1674 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1812 1825 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1853 1866 <span type="species:ncbi:5207">C. neoformans</span>
###xml 2027 2032 <span type="species:ncbi:9606">Human</span>
###xml 2157 2170 <span type="species:ncbi:5207">C. neoformans</span>
###xml 2333 2346 <span type="species:ncbi:5207">C. neoformans</span>
The lung epithelium represents much more than a simple protective physical barrier between the external environment and underlying tissues. In fact, both constitutive and inducible defense mechanisms of the airway lining are now recognized as fundamental elements of an effective antimicrobial environment [12]. The role of the airway lining as a highly responsive and multifunctional interface in the host innate immune response against various microorganisms has been summarized in several recent reviews [12,13]. C. neoformans has been shown to bind to the A549 human alveolar cell line in a time- and temperature-dependent manner, with apparent internalization [14]. This report demonstrated that factors such as yeast culture age and in vitro growth conditions influenced lung epithelial cell binding by various strains of C. neoformans and showed greater adherence to A549 cells in the absence of a polysaccharide capsule [14]. Using the same cell line, another group recently reported that purified GXM, the major capsular component of C. neoformans, could induce IL-8 secretion after binding to the CD14 receptor [15,16]. Finally, the multifunctional enzyme secretory phospholipase B (PLB1) has also been shown to play a role in the adhesion process of C. neoformans to the alveolar epithelium [17]. To the best of our knowledge, there have been no studies characterizing the interaction between C. neoformans and cells of the airway lining that represent a first site of contact for airborne pathogens. Therefore, we investigated the ability of immortalized and normal human bronchial epithelial cells to trigger a host inflammatory response to viable C. neoformans. We found that BEAS-2B cells produced the potent chemokine IL-8 in an AP-1 and NF-kappaB dependent manner when stimulated with acapsular C. neoformans. The presence of acapsular C. neoformans also led to an increase in expression of the chemokine CXCL1 as well as the transcription factor CAAT/enhancer-binding protein beta (CEBP/beta). Primary Normal Human Bronchial Epithelial cells also secreted more IL-8 and exhibited significantly greater cell damage in response to acapsular C. neoformans compared to stimulation with an encapsulated strain. Together these data clearly demonstrate that airway epithelial cells mount a strong inflammatory response to C. neoformans that is modulated by the presence of the polysaccharide capsule.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Reagents and antibodies
###end title 14
###begin p 15
###xml 302 309 298 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. Coli</italic>
###xml 398 402 394 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 161 165 <span type="species:ncbi:9913">calf</span>
###xml 208 213 <span type="species:ncbi:9606">Human</span>
F-12K nutrient mixture (Kaighn's modification), penicillin/streptomycin, glutamine, and trypsin-EDTA were from GIBCO Life Technologies, Ltd (Paisley, UK). Fetal calf serum (FCS) was from Hyclone (Logan, UT). Human recombinant TNF-alpha was from R&D systems (Minneapolis, MN). Lipopolysaccharide (LPS) (E. Coli, O55:B5) and fluorescein isothiocyanate (FITC) were from Sigma (Oakville, ON). Diff-Quik(R) stain set was from Dade Behring (Newark, DE).
###end p 15
###begin title 16
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 0 13 <span type="species:ncbi:5207">C. neoformans</span>
C. neoformans strains
###end title 16
###begin p 17
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 401 415 401 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 342 347 <span type="species:ncbi:9606">human</span>
###xml 401 414 <span type="species:ncbi:5207">C. neoformans</span>
Wild type B3501, mutant CAP64, and 52D cryptococcal strains (34873, 52816, and 24067, respectively) were obtained from the American Type Culture Collection (ATCC, Manassas, VA). CAP64 is an avirulent capsule-deficient mutant [18,19] derived from the parental laboratory strain B3501. Strain 52D is a moderately virulent clinical isolate from human cerebrospinal fluid. Capsular and acapsular forms of C. neoformans were grown and maintained on Sabouraud dextrose agar (BD, Sparks, MD). For cell stimulation, a single colony suspension in Sabouraud dextrose broth (BD, Sparks, MD) was prepared and grown to early stationary phase (48 h) at room temperature or 37degreesC with continuous rotation. The culture was then washed with PBS, counted on a hemacytometer, and diluted to the desired concentration in cell culture media.
###end p 17
###begin title 18
Cells and culture conditions
###end title 18
###begin p 19
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 193 195 193 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 274 275 268 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 563 565 551 553 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 713 715 701 703 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 876 889 864 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 458 463 <span type="species:ncbi:9606">Human</span>
###xml 876 889 <span type="species:ncbi:5207">C. neoformans</span>
The BEAS-2B human tracheobronchial epithelial cell line was obtained from the ATCC (CRL-9609) and cultured as described previously [20]. For stimulation experiments, cells were seeded at 2 x 105 cells on 12-well plates (Costar, New York, NY) and grown at 37degreesC in 5% CO2. Forty-eight hours later, cells were washed once and triplicate wells were stimulated with various multiplicities of infection (MOI) as described in the figure legends. NHBE (Normal Human Bronchial Epithelial) cells from Cambrex (Walkersville, MD) were maintained at 37degreesC and 5% CO2 and subcultured in Bronchial Epithelial Growth Medium (BEGM) as recommended by the manufacturer. For stimulation, NHBE were seeded at 10000 cells/cm2 in 12-well plate (Costar). Forty-eight hours later, cells were counted and triplicate wells were stimulated with an MOI of 20 of acapsular CAP64 or capsular 52D C. neoformans.
###end p 19
###begin title 20
RT-PCR
###end title 20
###begin p 21
###xml 925 927 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 298 303 <span type="species:ncbi:9606">human</span>
###xml 792 797 <span type="species:ncbi:9606">human</span>
Total RNA was extracted using an RNeasy kit (Qiagen, Mississauga). Reverse transcription (RT) was performed with 0.5 mug of total RNA that had been extracted, using the ABI high capacity cDNA archive kit (ABI, Foster City, CA). PCR was performed using specific primers (AlphaDNA, Montreal, QC) for human CEBP/beta (sense: 5'-GAC AAG CAC AGC GAC GAG TA-3'; antisense: 5'-AGC TGC TCC ACC TTC TTC TG-3' - amplicon size 158 bp), CXCL-1 (sense: 5'-AGG GAA TTC ACC CCA AGA AC-3'; antisense: 5'-CAC CAG TGA GCT TCC TCC TC-3' - amplicon size 204 bp), CCL2 (sense: 5'-TCC AGC ATG AAA GTC TCT GC-3'; antisense: 5'-TGG AAT CCT GAA CCC ACT TC-3'-amplicon size 265 bp); the CCL15 primer set was obtained from SuperArray - amplicon size 150 bp. As an internal control, we used primers for the detection of human beta-actin (sense 5'-AAG GAG AAG CTG TGC TAC GTC GC-3'; antisense 5'-AGA CAG CAC TGT GTT GGC GTA CA-3' - amplicon size 266 bp [20]). PCR amplifications were performed in a Peltier thermal cycler apparatus (MJ Research, Watertown, MA) using the Amplitaq polymerase (ABI, Foster City, CA). For the detection of CEBP/beta, CXCL1 and CCL2 the thermocycling protocol was: 95degreesC for 1 min, 30 cycles of denaturation at 95degreesC for 45 s, annealing at 56degreesC for 45 s, and extension at 72degreesC for 1 min. For the detection of CCL15, 34 cycles were applied; for the detection of beta-actin, 24 cycles were applied. Amplification products were resolved on a 1.5% agarose gel containing ethidium bromide and recorded with a Gene Genius bioimaging system (Syngene, Frederick, MD). Different cycle numbers for each target were performed to verify that each PCR product was analyzed during the exponential phase of the amplification reaction.
###end p 21
###begin title 22
Real time PCR
###end title 22
###begin p 23
###xml 157 161 156 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 165 169 162 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 207 211 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 231 235 224 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 270 271 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1361 1376 1307 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916;CtCt</sup>
Real-time PCR was performed using an ABI Prism 7500 Real time PCR System (Applied Biosystems, Foster City, CA). Each reaction contained 10 mul of 2x platinum(R) SYBR(R) Green PCR Supermix (including Platinum(R) Taq polymerase, SYBR(R) green dye, Tris-HCL, KCL, 6 mM MgCl2, 400 muM dATP, 400 muM dCTP, 400 muM dGTP, 800 muM dUTP, Uracil DNA glycosylase (UDG) and stabilizers) (Invitrogen, Carlsbad, CA), 0.04 mul of ROX reference dye, 0.2 muM of each of forward and reverse primers (same as described above), and 25 ng of cDNA as template in a final volume of 20 mul. Reactions were incubated at 50degreesC for 2 min followed by 95degreesC for 10 min. The amplification profile was 15 s denaturation at 95degreesC followed by 40 s annealing at 60degreesC for a total of 40 cycles. Then a dissociation curve was realized to analyze the specificity of the reaction and the amplification of the expected single products was confirmed on 1.5% agarose gels stained with ethidium bromide (data not shown). Data were analyzed with the comparative Ct method (DeltaDeltaCt) outlined in the ABI user manual with the 7500 system SDS software (Applied Biosystems). For the relative quantification, the amount of the targets CCL2, CXCL1 and CEBP/beta were normalized to beta-actin (endogenous gene) relative to unstimulated cells used as the calibrator and calculated using 2-DeltaDeltaCtCt.
###end p 23
###begin title 24
###xml 12 26 12 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 12 25 <span type="species:ncbi:5207">C. neoformans</span>
Analysis of C. neoformans binding
###end title 24
###begin p 25
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 136 150 136 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 274 278 274 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 136 149 <span type="species:ncbi:5207">C. neoformans</span>
BEAS-2B cells were seeded at 2 x 105 on individual coverslips (Fisher scientific, Pittsburg, PA) in a 12-well plate and stimulated with C. neoformans as indicated in the figure legends. Twenty-four hour later, cells were washed twice with PBS and then stained with Diff-Quik(R) products. Slides images were captured with a Retiga 1300 C digital camera (QImaging Corp., Burnaby, BC) attached to a Zeiss AxioSkop II (Carl Zeiss Canada Ltd., Toronto, ON) light microscope.
###end p 25
###begin title 26
Fluorescence Activated Cell Sorter (FACS) Analysis
###end title 26
###begin p 27
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 97 111 97 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 273 287 273 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 97 110 <span type="species:ncbi:5207">C. neoformans</span>
###xml 273 286 <span type="species:ncbi:5207">C. neoformans</span>
BEAS-2B cells were seeded at 2 x 105 on 12-well plates and grown for 48 h. Fluorescently labeled C. neoformans was prepared by incubation with 0.5 mg/ml FITC for 10 minutes, followed by three washes with PBS, as previously described [21]. BEAS-2B cells were incubated with C. neoformans for 3 hours, then washed twice with PBS, and trypsinized. Cells were subsequently incubated in the presence or absence of the extracellular dye quencher Trypan blue (200 mug/ml), washed three times with PBS, and their fluorescence was analyzed using a FACScalibur (BD Biosciences, San Jose, CA).
###end p 27
###begin title 28
Epithelial cell transfection and reporter gene studies
###end title 28
###begin p 29
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 360 362 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 455 469 451 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 631 633 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 455 468 <span type="species:ncbi:5207">C. neoformans</span>
BEAS-2B cells were seeded at 7 x 104 on 24 well plates (Costar) 24 h before transfection using FuGENE 6 transfection reagent (Roche Molecular Diagnostics, Indianapolis, IN) according to the manufacturer's instructions. Cells were transfected with 200 ng of -133-luc, NFkappaB mutated-luc and AP-1-mutated-luc IL-8 luciferase constructions described elsewhere [22]. After 48 h, cells were left untreated or stimulated for 6 h with a MOI of 20 of acapsular C. neoformans or 20 ng/ml of TNF-alpha. Cell lysates were obtained by treatment with passive lysis buffer and firefly luciferase activity was measured as described previously [20], using a Lmax (Molecular Devices, Sunnyvale, CA) apparatus. Results are expressed as relative luciferase units (RLU).
###end p 29
###begin title 30
Gene Expression Array Studies
###end title 30
###begin p 31
###xml 177 181 177 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 299 312 297 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 299 312 <span type="species:ncbi:5207">C. neoformans</span>
Human cytokine and receptor microarrays profiling a total of 113 cytokines, chemokines, and the corresponding receptor genes involved in the inflammatory response (Oligo GEArray(R) OHS-011, SuperArray, Bethesda, MD) were used to evaluate the gene expression profile of BEAS-2B cells stimulated with C. neoformans. Total cellular RNA (0.8 mug) was used as the template to produce biotin-labeled amplified cRNA; subsequent hybridization of the microarrays was performed with 3 mug of biotin labeled cRNA. Microarray analysis was performed as manufacturer's recommendations. An image of each array was taken and saved using a Gene Genius bioimaging system (Syngene) followed by analysis using the GEArray Expression analysis software. The relative amount of each target gene transcript was estimated by comparing its signal intensity with the signal derived from two housekeeping genes (beta-actin, GAPDH).
###end p 31
###begin title 32
Cytokine and LDH measurements
###end title 32
###begin p 33
###xml 189 193 189 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 14 19 <span type="species:ncbi:9606">human</span>
The levels of human IL-8 and lactate dehydrogenase (LDH) in cell culture supernatants were determined using a DuoSet ELISA kit (R&D systems, Minneapolis, MN) and a LDH assay kit (CytoTox 96(R) Non-radioactive cytotoxicity assay, Promega, Madison, WI), respectively.
###end p 33
###begin title 34
Statistical Analysis
###end title 34
###begin p 35
Each point corresponds to the mean +/- S.D. of the indicated number of experiments. The statistical significance of single comparisons was analyzed using the unpaired Student's t test with a threshold of P </= 0.05. For multiple comparisons, statistical significance was determined by a one-way ANOVA with post-test comparisons using the Tukey test with a threshold of P </= 0.05.
###end p 35
###begin title 36
Results
###end title 36
###begin title 37
###xml 10 24 10 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 10 23 <span type="species:ncbi:5207">C. neoformans</span>
Acapsular C. neoformans stimulates IL-8 production by BEAS-2B cells
###end title 37
###begin p 38
###xml 158 167 158 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 191 204 191 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 307 321 307 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 583 597 577 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 918 920 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1124 1138 1106 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1229 1231 1205 1207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1251 1253 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1383 1385 1359 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1491 1493 1467 1469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1553 1567 1529 1543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1604 1606 1580 1582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 191 204 <span type="species:ncbi:5207">C. neoformans</span>
###xml 307 320 <span type="species:ncbi:5207">C. neoformans</span>
###xml 324 329 <span type="species:ncbi:9606">human</span>
###xml 393 398 <span type="species:ncbi:4932">yeast</span>
###xml 494 499 <span type="species:ncbi:4932">yeast</span>
###xml 583 596 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1124 1137 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1553 1566 <span type="species:ncbi:5207">C. neoformans</span>
To determine whether airway epithelial cells are able to mediate an anti-cryptococcal response, we measured IL-8 protein secretion by human BEAS-2B following in vitro stimulation with viable C. neoformans. In accordance with a previous study that demonstrated capsule- and temperature-dependent adhesion of C. neoformans to human alveolar epithelium [14], both encapsulated and unencapsulated yeast forms were grown at room temperature (RT) as well as 37degreesC prior to cell stimulation. All yeast cultures were grown to late log phase prior to use. The in vitro growth kinetic of C. neoformans was comparable between the encapsulated and unencapsulated forms; however, higher growth rates for both strains were achieved at room temperature (data not shown). Stimulation of BEAS-2B cells with the encapsulated B3501 strain did not induce significant release of IL-8, regardless of whether it was grown at RT (Figure 1A) or 37degreesC (data not shown). The same results were also observed following stimulation of BEAS-2B with the encapsulated 52D strain grown at RT and 37degreesC (data not shown). In contrast, acapsular C. neoformans cultured at 37degreesC triggered substantial secretion of IL-8 in a concentration- (Figure 1B) and time- (Figure 1C) dependent manner in BEAS-2B cells. The amount of IL-8 secretion was significantly increased with a MOI of 20 or greater (Figure 1B); this was observed by 6 h post-stimulation and accumulated in the culture medium for up to 24 h (Figure 1C). No IL-8 production was observed in response to acapsular C. neoformans that had been cultured at RT (Figure 1D).
###end p 38
###begin p 39
###xml 10 24 10 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 244 258 244 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 455 468 454 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 518 532 517 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 620 634 619 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 893 895 884 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 908 910 897 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 924 926 911 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 10 23 <span type="species:ncbi:5207">C. neoformans</span>
###xml 244 257 <span type="species:ncbi:5207">C. neoformans</span>
###xml 455 468 <span type="species:ncbi:5207">C. neoformans</span>
###xml 518 531 <span type="species:ncbi:5207">C. neoformans</span>
###xml 620 633 <span type="species:ncbi:5207">C. neoformans</span>
Acapsular C. neoformans induces IL-8 production by BEAS-2B cells in a dose, time, and temperature dependent manner. (A) BEAS-2B cells were unstimulated (NS, white box) or stimulated (black box) for 24 h with various MOI (100, 50, 20, 10, 1) of C. neoformans B3501 cultured at RT; LPS (1 mug/ml) was used as a positive stimulus. B) BEAS-2B cells were untstimulated (NS, white box) or stimulated for 24 h with various MOI (50, 20, 10, 5 and 1) of acapsular C. neoformans. C) BEAS-2B cells were stimulated with acapsular C. neoformans (MOI of 20) for 6 h and 24 h. (D) BEAS-2B cells were stimulated for 24 h with acapsular C. neoformans (MOI of 20) grown at 37degreesC or RT. The cell supernatants were collected and ELISA was used to measure IL-8 concentrations. All results are expressed as the mean +/- S.D. of triplicate measurements and are representative of three independent experiments; *P </= 0.05, ** P </= 0.01, *** P </= 0.001 relative to NS.
###end p 39
###begin title 40
###xml 10 24 10 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 10 23 <span type="species:ncbi:5207">C. neoformans</span>
Acapsular C. neoformans binds and tightly associates with BEAS-2B cells
###end title 40
###begin p 41
###xml 104 118 104 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 199 213 199 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 279 280 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 308 317 302 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 342 356 336 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 402 404 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 563 565 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2I</xref>
###xml 658 672 646 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 777 791 765 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 870 884 858 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 924 926 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1022 1035 1010 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1050 1064 1038 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1268 1282 1255 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1421 1423 1396 1398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1428 1430 1403 1405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2G</xref>
###xml 1511 1525 1486 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1627 1629 1600 1602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 1718 1732 1691 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1957 1971 1930 1944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 2014 2016 1979 1981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2H</xref>
###xml 2127 2141 2092 2106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 104 117 <span type="species:ncbi:5207">C. neoformans</span>
###xml 199 212 <span type="species:ncbi:5207">C. neoformans</span>
###xml 342 355 <span type="species:ncbi:5207">C. neoformans</span>
###xml 411 416 <span type="species:ncbi:4932">yeast</span>
###xml 583 588 <span type="species:ncbi:4932">yeast</span>
###xml 658 671 <span type="species:ncbi:5207">C. neoformans</span>
###xml 777 790 <span type="species:ncbi:5207">C. neoformans</span>
###xml 794 799 <span type="species:ncbi:9606">human</span>
###xml 870 883 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1022 1035 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1050 1063 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1268 1281 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1511 1524 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1718 1731 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1957 1970 <span type="species:ncbi:5207">C. neoformans</span>
###xml 2127 2140 <span type="species:ncbi:5207">C. neoformans</span>
Light microscopy of differentially stained co-cultures was used to characterize the interaction between C. neoformans and BEAS-2B cells. After washing and staining, a stable association of acapsular C. neoformans grown at RT or 37degreesC with BEAS-2B cells was observed (Figure 2). Interestingly, prominent in vitro aggregation of acapsular C. neoformans was observed when grown at 37degreesC (Figure 2E). The yeast-host cell interaction was resistant to trypsinization and appeared to be confined to the cell surface without evidence of internalization (Figure 2I). Conversely, no yeast-epithelial cell association was evident for the encapsulated form of C. neoformans (data not shown). A previously established technique to analyze the association and uptake of serotype A C. neoformans by human peripheral blood monocytes was then used to examine whether acapsular C. neoformans could be internalized by BEAS-2B cells [21]. We initially confirmed the efficacy of trypan blue to quench fluorescently labeled acapsular C. neoformans; FITC-labeled C. neoformans cells were homogenously fluorescent (99.5%) and this signal was almost completely eliminated (97.5%) by 200 mug/ml of trypan blue (data not shown). Incubation of BEAS-2B cells with FITC-labeled acapsular C. neoformans grown at RT or 37degreesC led to an increase in fluorescence (FL1-H) for 7.5% and 10.4% of BEAS-2B cells grown at RT or 37degreesC (Figure 2C and 2G, respectively). Following trypan blue treatment of BEAS-2B cells complexed with C. neoformans grown at RT, clear inhibition of the mean fluorescence intensity was observed (66.9% +/- 4.5%; Figure 2D) and only 0.9% of cells retained the fluorescent label. This observation indicates that C. neoformans grown at RT is able to bind BEAS-2B cells but remains accessible to the quenching reagent. Comparable inhibition of the mean fluorescence intensity was observed following trypan blue treatment of BEAS-2B cells complexed with C. neoformans grown at 37degreesC (78.9 +/- 0.7%; Figure 2H) however, 6.8% of BEAS-2B cells retained the fluorescent label, indicating that a small fraction of acapsular C. neoformans grown at 37degreesC is inaccessible to quenching by trypan blue.
###end p 41
###begin p 42
###xml 10 24 10 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 170 184 170 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 398 412 386 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 10 23 <span type="species:ncbi:5207">C. neoformans</span>
###xml 170 183 <span type="species:ncbi:5207">C. neoformans</span>
###xml 398 411 <span type="species:ncbi:5207">C. neoformans</span>
Acapsular C. neoformans binds and is internalized by BEAS-2B cells. Light microscopy of differentially stained BEAS-2B cells that were stimulated for 24 h with acapsular C. neoformans cultured at RT (A), 37degreesC (E), or 37degreesC followed by trypsinization (I). Flow cytometric analysis of BEAS-2B cells that were stimulated for 3 h with unlabeled (B and F) or FITC-labeled (C and G) acapsular C. neoformans grown at RT or 37degreesC respectively, and then quenched with trypan blue (D and H). Data are representative of three independent experiments.
###end p 42
###begin title 43
###xml 10 24 10 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 10 23 <span type="species:ncbi:5207">C. neoformans</span>
Acapsular C. neoformans induces mild LDH release from BEAS-2B cells
###end title 43
###begin p 44
###xml 21 35 21 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 194 208 194 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 254 268 254 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 726 728 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 21 34 <span type="species:ncbi:5207">C. neoformans</span>
###xml 194 207 <span type="species:ncbi:5207">C. neoformans</span>
###xml 254 267 <span type="species:ncbi:5207">C. neoformans</span>
To determine whether C. neoformans is able to induce damage of bronchial epithelial cells, release of the intracellular enzyme LDH was measured following incubation of BEAS-2B cells with viable C. neoformans for 24 hours. As shown in Figure 3, acapsular C. neoformans grown at RT or 37degreesC induced a relatively small amount of LDH release by BEAS-2B cells (7 +/- 7.1% and 12 +/- 6.7%, respectively) that is indicative of mild cytotoxicity compared to cells that were completely lysed with Triton (100%). To confirm the validity of the assay using a relevant biological stimulus, BEAS-2B cells were also incubated with a high dose of TNFalpha (50 ng/ml), an inflammatory cytokine that is known to induce cell cytotoxicity [23]. As expected, TNFalpha induced substantial LDH release (35 +/- 13.6%) by BEAS-2B cells.
###end p 44
###begin p 45
###xml 10 24 10 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 169 183 169 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 10 23 <span type="species:ncbi:5207">C. neoformans</span>
###xml 169 182 <span type="species:ncbi:5207">C. neoformans</span>
Acapsular C. neoformans induces mild LDH release by BEAS-2B cells. BEAS-2B cells were left untreated (NS, white box) or stimulated for 24 h with a MOI = 20 of acapsular C. neoformans grown at RT or 37degreesC or 50 ng/ml of TNF-alpha. Supernatants were collected and assayed for LDH release using colorimetry. Data represent the mean +/- S.D. of triplicate measurements from two independent experiments and are expressed as a percentage of LDH release from unstimulated BEAS-2B cells treated with a detergent lysis solution (triton).
###end p 45
###begin title 46
IL-8 activation in BEAS-2B cells largely involves the transcription factor AP-1 and NF-kappaB
###end title 46
###begin p 47
###xml 277 279 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 404 417 400 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 683 697 679 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 786 788 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1020 1022 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1262 1263 1250 1251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1456 1458 1440 1442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1670 1672 1646 1648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1682 1684 1658 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 404 417 <span type="species:ncbi:5207">C. neoformans</span>
###xml 683 696 <span type="species:ncbi:5207">C. neoformans</span>
Activation of transcription factors is required in many signal transduction pathways. For instance, IL-8 production can be activated in response to many different infectious or inflammatory conditions and is largely dependent on the transcription factor NF-kappaB and/or AP-1 [24]. To confirm whether these two signaling mechanisms are active in bronchial epithelial cells upon in vitro stimulation with C. neoformans, we examined IL-8 promoter activation using luciferase reporter plasmids bearing engineered mutations of either transcription factor-binding site. Consistent with the data obtained by ELISA, we detected IL-8 luciferase activity 6 h after stimulation with acapsular C. neoformans in BEAS-2B cells transfected with a wild-type IL-8 luciferase plasmid (-133-luc) (Figure 4A). A clear reduction of inducible IL-8 luciferase activity was observed following transfection of BEAS-2B cells with IL-8 reporter constructs mutated at the AP-1 (AP-1 mut-luc) or NF-kappaB (NF-kappaB mut-luc) binding sites (Figure 4A). Under these conditions we also observed an inhibition of basal IL-8 luciferase activity in unstimulated wells which is consistent with the observation that BEAS-2B cells constitutively release a detectable amount of IL-8 protein (Figure 1). To confirm the specificity of the mutated plasmid constructs, TNFalpha-induced stimulation of IL-8 reporter activity in BEAS-2B cells was performed as a positive control for IL-8 induction [24]. Consistent with previous reports using airway epithelial cells, we observed strong IL-8 luciferase activity in response to TNFalpha that was primarily dependent on NF-kappaB with a minor contribution of AP-1 [25] (Figure 4B).
###end p 47
###begin p 48
###xml 29 43 29 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 447 461 435 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 29 42 <span type="species:ncbi:5207">C. neoformans</span>
###xml 447 460 <span type="species:ncbi:5207">C. neoformans</span>
IL-8 activation by acapsular C. neoformans is dependent on NF-kappaB and AP-1. BEAS-2B cells were transiently transfected in duplicate with 200 ng of luciferase reporter plasmid DNA bearing the wild type IL-8 promoter (-133-luc), or mutations (mut) of its AP-1 (AP-1-mut-luc) or NF-kappaB (NF-kappaB-mut-luc) binding sites. After overnight incubation, cells were left untreated (white columns) or stimulated (black columns) for 6 h with acapsular C. neoformans (MOI = 20) (A) or TNF-alpha (20 ng/ml) (B). Cell lysates were collected and assayed for luciferase activity expressed as relative luciferase units (RLU). Data are shown as the mean +/- S.D. Results are representative of three independent experiments.
###end p 48
###begin title 49
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 0 13 <span type="species:ncbi:5207">C. neoformans</span>
C. neoformans induces expression of the chemokine CXCL1 and the transcription factor CEBP/beta in BEAS-2B cells
###end title 49
###begin p 50
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 549 562 549 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 682 684 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 689 691 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 848 850 842 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 855 857 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 935 949 926 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1099 1112 1090 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 80 93 <span type="species:ncbi:5207">C. neoformans</span>
###xml 459 472 <span type="species:ncbi:5207">C. neoformans</span>
###xml 549 562 <span type="species:ncbi:5207">C. neoformans</span>
###xml 935 948 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1099 1112 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1208 1213 <span type="species:ncbi:9606">human</span>
To further characterize the activation profile of bronchial epithelial cells by C. neoformans, we used an oligonucleotide microarray in order to examine the induction of a panel of 113 inflammatory cytokines, chemokines, and their receptors (a complete list of genes represented on the microarray is available on request). In unstimulated cells, we observed constitutive expression of C3, C4A, CXCL-10, MIF and TNFR1A that was not significantly influenced by C. neoformans stimulation (Figure 5A). Twenty-four hours after stimulation with acapsular C. neoformans, we observed the induction of IL-8, as expected, as well as up-regulation of CCL2, CXCL1, CCL15, and CEBP/beta (Figure 5A and 5B). To validate these observations, we analyzed the expression of CXCL1, CCL2, and CEBP/beta, and CCL15 by qualitative and real-time PCR. As shown in Figures 6C and 6D, we confirmed modest up-regulation of CXCL-1 and CEBP/beta, but not CCL2, in C. neoformans stimulated cells compared to untreated BEAS-2B cells. Surprisingly, we were not able to demonstrate the expression of CCL15 either in unstimulated or C. neoformans-stimulated BEAS-2B cells by RT-PCR; nevertheless, we were able to weakly amplify CCL15 using a human reference cDNA as a positive control (kindly provided by SuperArray; data not shown). The integrity of all RNA preparations was verified by RT-PCR analysis of beta-actin expression.
###end p 50
###begin p 51
###xml 89 102 89 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 206 220 206 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 634 647 628 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 89 102 <span type="species:ncbi:5207">C. neoformans</span>
###xml 206 219 <span type="species:ncbi:5207">C. neoformans</span>
###xml 634 647 <span type="species:ncbi:5207">C. neoformans</span>
BEAS-2B cells induce chemokine gene expression in response to stimulation with acapsular C. neoformans. (A) BEAS-2B cells were left unstimulated (NS) (left panel) or stimulated (right panel) with acapsular C. neoformans MOI = 20 cultured at 37degreesC. Twenty-four hours later, RNA was extracted and analyzed by microarray for expression of inflammatory cytokines and their receptors. A box indicates the location of endogenous control (housekeeping) genes; glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and beta-2 microglobulin (B2M) were used for normalization. (B) Summary of relative gene expression following stimulation with C. neoformans. Data shown is representative of three independent experiments. *Not determined due to undetectable IL-8 expression in untreated cells. (C) Expression of CCL2, CXCL1, and CEBP/beta was analyzed by RT-PCR; beta-actin was used as an endogenous control. (D) Relative quantification of CXCL1, CCL2, and CEBP/beta expression in untreated (white columns) and stimulated (black columns) BEAS-2B cells was determined by real time PCR. Results are representative of three independent experiments.
###end p 51
###begin p 52
###xml 96 109 96 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 220 234 220 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 990 992 971 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1011 1013 990 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1026 1028 1003 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1042 1044 1017 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 96 109 <span type="species:ncbi:5207">C. neoformans</span>
###xml 220 233 <span type="species:ncbi:5207">C. neoformans</span>
NHBE cells induce chemokine expression and are susceptible to damage following stimulation with C. neoformans. (A) NHBE cells were left unstimulated (NS, white box) or stimulated with a MOI = 20 of capsular or acapsular C. neoformans cultured at RT or 37degreesC, as indicated. Twenty-four hours later, supernatants were collected and ELISA was used to measure IL-8 concentrations. Results are expressed as the mean +/- S.D. of triplicate measurements and are representative of three independent experiments. (B) Supernatants were also assayed for LDH release using colorimetry. Data are expressed as a percentage of LDH release from unstimulated cells treated with a detergent lysis solution (triton) and represent the mean +/- S.D. of triplicate measurements from two independent experiments. (C, D) Relative quantification of CXCL1 and CEBP/beta expression was determined by real time PCR. Results are representative of the mean +/- S.D. of one experiment performed in triplicate; delta P </= 0.05 vs. NS, * P </= 0.05, ** P </= 0.01, *** P </= 0.001.
###end p 52
###begin title 53
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 0 13 <span type="species:ncbi:5207">C. neoformans</span>
C. neoformans is able to activate and damage primary NHBE cells
###end title 53
###begin p 54
###xml 99 113 99 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 274 287 274 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 650 664 650 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 897 910 897 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1009 1022 1009 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1130 1144 1124 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1294 1308 1276 1290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1396 1410 1378 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1524 1537 1500 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1558 1560 1534 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1572 1586 1548 1562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1756 1770 1724 1738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1815 1829 1781 1795 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 2042 2056 1995 2009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 2193 2207 2146 2160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 2241 2243 2188 2190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 2358 2360 2302 2304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 99 112 <span type="species:ncbi:5207">C. neoformans</span>
###xml 274 287 <span type="species:ncbi:5207">C. neoformans</span>
###xml 650 663 <span type="species:ncbi:5207">C. neoformans</span>
###xml 897 910 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1009 1022 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1130 1143 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1294 1307 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1396 1409 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1524 1537 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1572 1585 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1756 1769 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1815 1828 <span type="species:ncbi:5207">C. neoformans</span>
###xml 2042 2055 <span type="species:ncbi:5207">C. neoformans</span>
###xml 2193 2206 <span type="species:ncbi:5207">C. neoformans</span>
To exclude the possibility that IL-8 secretion and LDH release by BEAS-2B cell line in response to C. neoformans was a consequence of the viral immortalization process, we studied the response of primary NHBE cells to stimulation with an encapsulated or acapsular strain of C. neoformans. To more closely model conditions of authentic infection, a moderately virulent encapsulated clinical isolate, strain 52D, was used to stimulate primary cells. The NHBE cells used in this study were derived from a single male donor and had been extensively tested to exclude the presence of infectious agents. Interestingly, NHBE cells were highly responsive to C. neoformans and produced a significant amount of IL-8 in response to all conditions tested in comparison to NS (Figure 6A). Consistent with the observations using BEAS-2B cells, the maximal IL-8 secretion by NHBE cells was elicited by acapsular C. neoformans. In contrast to the BEAS-2B cell line, primary NHBE were activated by both acapsular and capsular C. neoformans, regardless of whether they were grown at RT or at 37degreesC. Nevertheless, we observed that the capsular C. neoformans grown at 37degreesC induced significantly lower IL-8 secretion in comparison to the acapsular strain grown at RT or 37degreesC. In contrast, capsular C. neoformans grown at RT elicited significantly lower IL-8 secretion only in comparison to acapsular C. neoformans grown at 37degreesC. NHBE cells were also highly susceptible to damage following a 24-hour incubation with viable C. neoformans. As shown in figure 6B, acapsular C. neoformans grown at 37degreesC induced the most significant LDH release by NHBE cells (44.6 +/- 5%) in comparison to all other conditions, including the level elicited by acapsular C. neoformans grown at RT (17.6 +/- 7%). Notably, capsular C. neoformans grown at RT or 37degreesC induced a relatively low amount of LDH release from NHBE cells (1.6 +/- 0.65% and 4.3 +/- 1.2, respectively). Finally, we examined transcriptional up regulation of CXCL1 and CEBP/beta by C. neoformans in NHBE cells. Using real-time PCR, we observed a 2- to 3-fold induction of CXCL1 gene expression in NHBE by both capsular and acapsular C. neoformans grown at RT or 37degreesC (Figure 6C); however, no clear induction of CEBP/beta was demonstrable under any of the experimental conditions used (Figure 6D).
###end p 54
###begin title 55
Discussion
###end title 55
###begin p 56
###xml 46 60 46 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 436 450 436 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 658 672 658 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 989 991 989 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 992 994 992 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1049 1063 1049 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 31 37 <span type="species:ncbi:9606">humans</span>
###xml 46 59 <span type="species:ncbi:5207">C. neoformans</span>
###xml 164 169 <span type="species:ncbi:4932">yeast</span>
###xml 403 408 <span type="species:ncbi:9606">human</span>
###xml 436 449 <span type="species:ncbi:5207">C. neoformans</span>
###xml 658 671 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1049 1062 <span type="species:ncbi:5207">C. neoformans</span>
It is clearly established that humans acquire C. neoformans infection from the environment, most likely through the inhalation of dehydrated or poorly encapsulated yeast particles termed infectious propagules. A high serologic prevalence in certain geographic regions despite low clinical infection rates suggests that in many cases the initial infection is mild or completely asymptomatic [26]. In the human lung, the host response to C. neoformans is presumed to start with alveolar macrophage activation, followed by the release of cytokines and chemokines that recruit inflammatory cells to the site of infection. In order for this interaction to occur, C. neoformans must transit the airways prior to reaching the alveolus, yet the responsiveness and contribution of the airway epithelium to host defense against cryptococcal infection is not well understood. The cells that line these passages have been increasingly recognized as an essential component of the host immune response [12,27]. The current study has shown that the interaction of C. neoformans with bronchial epithelial cells activates the expression of both transcription factors and chemokines that have well-established roles in host defense.
###end p 56
###begin p 57
###xml 85 98 85 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 507 520 507 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 840 841 840 841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 972 985 972 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1124 1138 1124 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1152 1161 1152 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1297 1311 1291 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1410 1412 1404 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1413 1415 1407 1409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1577 1586 1571 1580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1793 1802 1781 1790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1866 1880 1854 1868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1881 1883 1869 1871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1884 1886 1872 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1983 1985 1971 1973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 2127 2140 2115 2128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 85 98 <span type="species:ncbi:5207">C. neoformans</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 507 520 <span type="species:ncbi:5207">C. neoformans</span>
###xml 972 985 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1124 1137 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1297 1310 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1866 1879 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1964 1969 <span type="species:ncbi:10090">mouse</span>
###xml 2127 2140 <span type="species:ncbi:5207">C. neoformans</span>
As an initial step in the investigation of human lung epithelial responses to viable C. neoformans, we selected the SV-40 immortalized BEAS-2B bronchial epithelial cell line that is derived from normal human tissue and capable of microbial recognition [13,28,29]. For a primary measure of cell activation, we quantified the secretion of IL-8, a prototypical neutrophil chemokine. Interestingly, we observed significant IL-8 secretion only when the BEAS-2B cell line was stimulated with an acapsular form of C. neoformans. Acapsular cryptococci exhibited a stable association with BEAS-2B cells that was resistant to enzymatic treatment with trypsin as well as various physical manipulations including washing and centrifugation of cell cultures. The well known anti-phagocytic and immunomodulatory properties of the polysaccharide capsule [3] are a plausible explanation for the absence of significant IL-8 release by BEAS-2B cells following stimulation with encapsulated C. neoformans, as well as the lack of visible fungal-host cell association under these conditions. In addition to the acapsular state, we observed that C. neoformans must be grown in vitro at 37degreesC in order to elicit IL-8 secretion by BEAS-2B cells. Environmental cues including temperature are well-known regulators of C. neoformans signal transduction that in turn influence microbial growth as well as virulence in animal models [30,31]. These data suggest that one or more temperature-regulated microbial factors distinct from GXM are required for activation of BEAS-2B cells. Alternatively, the in vitro cell aggregation that was observed at 37degreesC may also have contributed to the activation of BEAS-2B cells, possibly through coalescence or cross-linking of cryptococcal host cell surface receptors. This in vitro phenomenon has also been described for various other strains of C. neoformans [32-35] and has been associated with increased adherence as well as phagocytosis by mouse macrophages [34]. On the basis of these initial observations, we chose to focus subsequent investigations on the interaction of BEAS-2B cells with acapsular C. neoformans.
###end p 57
###begin p 58
###xml 19 33 19 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 404 418 404 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 758 772 758 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1974 1988 1950 1964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 19 32 <span type="species:ncbi:5207">C. neoformans</span>
###xml 404 417 <span type="species:ncbi:5207">C. neoformans</span>
###xml 758 771 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1974 1987 <span type="species:ncbi:5207">C. neoformans</span>
Internalization of C. neoformans by the A549 alveolar cell line has been demonstrated by two previous studies [14,15]. In one case, host cell damage following internalization of an encapsulated serotype A clinical isolate was also documented [15]. To determine whether BEAS-2B bronchial epithelial cells are also capable of fungal internalization, we first examined differentially stained co-cultures of C. neoformans and BEAS-2B cells by light microscopy. Despite the stable fungal-host cell interaction described above, no clear evidence of fungal internalization was directly visible. We then used a more sensitive flow cytometry technique combined with quenching of trypan blue dye to examine the interaction of BEAS-2B cells with FITC-labeled acapsular C. neoformans [21]. A clear increase in mean fluorescence intensity of BEAS-2B cells was observed following incubation with labeled cryptococci that were grown at 20degrees or at 37degreesC, verifying stable fungal binding in both conditions. The observation that only a minority of cells exhibited an increase in fluorescent signal may be attributable to partial disruption of fungal-host cell interactions by the washing, trypsinization, and centrifugation steps used to prepare the sample for cytometry. Quenching of fluorescence was almost complete for cryptococci grown at 20degreesC, a finding that is indicative of an extracellular fungal location. Interestingly, the residual fluorescence observed with fungi grown at 37degreesC indicates that they were either very tightly associated with the cell surface or may have been internalized by BEAS-2B cells. The extent of this process appeared to be quite limited as only a small percentage of fungi retained the trypan blue label. Further studies using a more detailed direct visualization technique such as electron microscopy will be required to confirm and discriminate between these two possibilities. Finally, limited damage of BEAS-2B cells by acapsular C. neoformans grown at 20degreesC or 37degreesC was observed by measurement of the intracellular enzyme LDH in cell supernatants following co-incubation.
###end p 58
###begin p 59
###xml 540 553 536 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 649 651 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 724 738 720 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 981 995 974 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1006 1008 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1218 1220 1208 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1379 1381 1362 1364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1490 1504 1466 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 540 553 <span type="species:ncbi:5207">C. neoformans</span>
###xml 724 737 <span type="species:ncbi:5207">C. neoformans</span>
###xml 741 746 <span type="species:ncbi:9606">human</span>
###xml 965 970 <span type="species:ncbi:10090">mouse</span>
###xml 981 994 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1090 1094 <span type="species:ncbi:10090">mice</span>
###xml 1099 1105 <span type="species:ncbi:9606">humans</span>
###xml 1490 1503 <span type="species:ncbi:5207">C. neoformans</span>
In order to identify the signaling pathways that mediate IL-8 release by BEAS-2B cells in response to cryptococci, we performed transient transfections of a luciferase reporter plasmid downstream of the wild type human IL-8 promoter or engineered constructs bearing mutations of the NF-kappaB or AP-1 transcription factor binding sites. Compared to the wild type promoter sequence, luciferase activity was reduced for each of the mutant plasmids, demonstrating a role for both of these transcription factors in the up-regulation of IL-8 by C. neoformans. These observations are consistent with known regulation of IL-8 by other microbial pathogens [24]. We also detected up-regulation of several other inflammatory genes by C. neoformans in human BEAS-2B cells using an oligonucleotide microarray and confirmed the hybridization data by conventional and real-time PCR for CXCL1 and CEBP/beta. CXCL1 has already been shown to be involved in leukocyte recruitment in mouse models of C. neoformans infection [36], indicating that activation of this chemokine is likely to be conserved between mice and humans. CEBP/beta is expressed by alveolar and bronchial epithelium and is particularly involved in acute lung injury [37]. Interestingly, CEBP/beta is also known to bind the IL-8 promoter in lung epithelial cells and activate transcription in a cooperative manner with NFkappaB [38]. Therefore, in addition to NF-kappaB and AP-1, CEBP/beta activation in BEAS-2B cells upon stimulation with C. neoformans may also contribute to the up-regulation of IL-8 expression.
###end p 59
###begin p 60
###xml 129 143 129 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 226 235 226 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 320 333 320 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 454 468 448 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 623 637 617 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 643 652 637 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 738 747 726 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 906 920 894 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1069 1083 1057 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 1115 1123 1103 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1223 1236 1211 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1511 1524 1493 1506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 1628 1642 1604 1618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 2639 2653 2609 2623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 2850 2864 2814 2828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 129 142 <span type="species:ncbi:5207">C. neoformans</span>
###xml 320 333 <span type="species:ncbi:5207">C. neoformans</span>
###xml 454 467 <span type="species:ncbi:5207">C. neoformans</span>
###xml 623 636 <span type="species:ncbi:5207">C. neoformans</span>
###xml 906 919 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1031 1036 <span type="species:ncbi:9606">human</span>
###xml 1069 1082 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1223 1236 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1358 1363 <span type="species:ncbi:9606">human</span>
###xml 1511 1524 <span type="species:ncbi:5207">C. neoformans</span>
###xml 1628 1641 <span type="species:ncbi:5207">C. neoformans</span>
###xml 2161 2166 <span type="species:ncbi:9606">human</span>
###xml 2639 2652 <span type="species:ncbi:5207">C. neoformans</span>
###xml 2850 2863 <span type="species:ncbi:5207">C. neoformans</span>
In order to confirm the authenticity of the observations that were obtained using BEAS-2B cells, we studied the effect of viable C. neoformans on primary NHBE cells that had not been subject to viral immortalization or serial in vitro passage. We found that primary NHBE cells were highly responsive to stimulation with C. neoformans. Specifically, for all experimental conditions tested (capsular or acapsular strains grown either at RT or 37degreesC), C. neoformans was able to stimulate the secretion of IL-8 and the expression of CXCL1 by NHBE. The highest level of IL-8 secretion was observed in response to acapsular C. neoformans grown in vitro at 37degreesC. At the mRNA level, CXCL1 expression did not appear to be influenced by in vitro growth conditions; however, this result does not exclude the possibility that both IL-8 and CXCL1 protein expression are coordinately regulated in response to C. neoformans stimulation. The confirmation of IL-8 protein secretion and CXCL1 up-regulation in NHBE strongly suggests that human bronchial epithelium recognizes C. neoformans and is capable of activating an in vivo host inflammatory response. Despite the observation that NHBE appeared to be responsive to capsular C. neoformans, growth of this organism at 37degreesC significantly diminished the magnitude of IL-8 secretion, suggesting that primary human epithelial cells respond to temperature dependent changes in fungal metabolism. Primary NHBE were also most susceptible to the cytotoxic effect of C. neoformans, especially when stimulated with the acapsular form that had been cultured at 37degreesC. Encapsulated C. neoformans elicited very little LDH from NHBE compared to acapsular form, regardless of whether it was cultivated at room temperature or 37degreesC. The fact that both chemokine activation and cell damage were reduced in the presence of the cryptococcal polysaccharide capsule points to an immunomodulatory role for GXM at the airway lining. It is tempting to speculate that following cryptococcal inhalation, induction of the GXM polysaccharide capsule expression in response to a change from ambient environmental conditions to human body temperature could facilitate the initial stage of fungal growth in the airways by modifying or diminishing the inflammatory response of the bronchial epithelium. Although the precise mechanism by which capsule alters the host response is not known, one possibility is that the presence of GXM polysaccharide modulates the interaction of cryptococcal surface or secreted structures with the bronchial epithelium. This relative suppression of host immunity mediated by C. neoformans might, in some cases, favor the development of progressive pulmonary infection. Finally, the observation that IL-8 secretion and cell damage were greatest for NHBE at 37degreesC also suggests that C. neoformans expresses unidentified, temperature-regulated structures potentially involved in pathogenesis.
###end p 60
###begin p 61
###xml 114 127 114 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 165 179 165 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 393 406 387 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 506 520 500 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 584 598 578 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 740 754 725 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 114 127 <span type="species:ncbi:5207">C. neoformans</span>
###xml 165 178 <span type="species:ncbi:5207">C. neoformans</span>
###xml 393 406 <span type="species:ncbi:5207">C. neoformans</span>
###xml 506 519 <span type="species:ncbi:5207">C. neoformans</span>
###xml 584 597 <span type="species:ncbi:5207">C. neoformans</span>
###xml 740 753 <span type="species:ncbi:5207">C. neoformans</span>
###xml 947 952 <span type="species:ncbi:9606">human</span>
###xml 1129 1134 <span type="species:ncbi:9606">human</span>
Our data clearly demonstrate that both the immortalized BEAS-2B cell line and primary NHBE cells are activated by C. neoformans. Using either cell source, acapsular C. neoformans grown at 37degreesC elicited the maximal secretion of IL-8 and induced the greatest degree of cell damage. Transcriptional up regulation of CXCL1 was also exhibited by primary and immortalized cells in response to C. neoformans. The NHBE cells used in our report were somewhat more permissive to IL-8 secretion by encapsulated C. neoformans compared to BEAS-2B cells that were only activated by acapsular C. neoformans grown at 37degreesC. One other notable difference between primary and immortalized bronchial cells was the lack of CEBP/beta up regulation by C. neoformans in NHBE. The precise reasons for these variations are not known but may be attributable either to the immortalization and maintenance of the BEAS-2B cell line or the inherent variability among human donors. Since the current data is derived from the study of cells from a single individual, it will be important to confirm these observations using a larger number of primary human samples.
###end p 61
###begin p 62
###xml 160 173 160 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans</italic>
###xml 331 356 331 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Streptococcus pneumoniae </italic>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 687 688 687 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 748 750 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1245 1267 1245 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus fumigatus </italic>
###xml 1268 1270 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1321 1335 1321 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 160 173 <span type="species:ncbi:5207">C. neoformans</span>
###xml 331 355 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
###xml 586 592 <span type="species:ncbi:9606">humans</span>
###xml 1245 1266 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 1321 1334 <span type="species:ncbi:5207">C. neoformans</span>
In the lung, the inflammatory response of epithelial cells is likely integrated with alveolar macrophages to rapidly generate an innate immune response against C. neoformans. In this study, the amplitude of the IL-8 response was substantial, though relatively limited in comparison to highly pathogenic bacteria or viruses such as Streptococcus pneumoniae [39] or influenza virus [40], respectively. This modest inflammatory activation of the airway epithelium is consistent with the subtle clinical manifestations that are characteristic of cryptococcal respiratory tract infection in humans and may be one mechanism by which cryptococci are able to establish a latent infective state [2]. In contrast to studies with the A549 alveolar cell line [15,16], our results indicate that cryptococcal GXM polysaccharide down-regulates the activation of bronchial epithelial cells. We speculate that the acute inflammatory response may be even more limited among immune compromised hosts, resulting in insufficient airway cellular recruitment and a predisposition to the development of disseminated disease. Interestingly, modest IL-8 release was also recently demonstrated following the interaction of A549 cells with mycelial fragments and spores of Aspergillus fumigatus [41]. Taken together, these observations suggest that C. neoformans and perhaps other pathogenic fungi may escape the pulmonary innate immune response due to the limited extent of airway epithelial cell activation.
###end p 62
###begin title 63
Conclusion
###end title 63
###begin p 64
###xml 128 142 128 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. neoformans </italic>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 128 141 <span type="species:ncbi:5207">C. neoformans</span>
###xml 381 386 <span type="species:ncbi:4932">yeast</span>
Primary as well as immortalized human bronchial epithelial cells secrete IL-8 and up regulate the expression of CXCL1 following C. neoformans exposure. In addition, bronchial epithelial cells are susceptible to damage when stimulated with cryptococci. Activation and host airway cell damage appears to be modulated by capsule expression and the growth temperature of the infecting yeast. These host responses are very likely to represent an important component of the pulmonary innate immunity against this opportunistic pathogen.
###end p 64
###begin title 65
Competing interests
###end title 65
###begin p 66
The author(s) declare that they have no competing interests.
###end p 66
###begin title 67
Authors' contributions
###end title 67
###begin p 68
LG participated in the design of the study, performed cell culture and flow cytometry experiments, and drafted the manuscript. SC performed cell culture experiments, conducted statistical analysis, and drafted the manuscript. MB performed kinetic fungal culture experiments. SQ conceived of the study, supervised experiments, and critically revised the manuscript for important intellectual content. All contributors approved the final manuscript.
###end p 68
###begin title 69
Acknowledgements
###end title 69
###begin p 70
This work was supported by a grant from the Canadian Institutes of Health Research, a Canada Research Chair, and a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund to Salman Qureshi. Loic Guillot was supported by a postdoctoral fellowship from the McGill University Health Centre and a McLaughlin fellowship from McGill University.
###end p 70
###begin p 71
The authors are grateful to Dr. Sabah Hussain for providing IL-8 luciferase plasmid constructs, Dr. Sam David for microscopy facilities, and Dr. Markus Schnare for critical review of the manuscript.
###end p 71
###begin article-title 72
###xml 19 31 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 19 42 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
The Biology of the Cryptococcus neoformans Species Complex
###end article-title 72
###begin article-title 73
Cryptococcosis
###end article-title 73
###begin article-title 74
###xml 41 53 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 41 64 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Role of phagocytosis in the virulence of Cryptococcus neoformans
###end article-title 74
###begin article-title 75
###xml 57 69 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 57 80 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact Cr. neoformans
###end article-title 75
###begin article-title 76
Innate and adaptive determinants of host susceptibility to medically important fungi
###end article-title 76
###begin article-title 77
###xml 37 49 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 37 60 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells
###end article-title 77
###begin article-title 78
###xml 95 107 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 95 118 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans
###end article-title 78
###begin article-title 79
###xml 37 43 <span type="species:ncbi:10090">murine</span>
In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis
###end article-title 79
###begin article-title 80
###xml 11 23 <span type="species:ncbi:89924">Cryptococcus</span>
Macrophage-Cryptococcus interactions
###end article-title 80
###begin article-title 81
An innate immune system cell is a major determinant of species-related susceptibility differences to fungal pneumonia
###end article-title 81
###begin article-title 82
Innate immunity and pulmonary host defense
###end article-title 82
###begin article-title 83
The innate immune response of the respiratory epithelium
###end article-title 83
###begin article-title 84
Lung epithelium as a sentinel and effector system in pneumonia--molecular mechanisms of pathogen recognition and signal transduction
###end article-title 84
###begin article-title 85
###xml 28 40 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 28 51 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 57 62 <span type="species:ncbi:9606">human</span>
The in vitro interaction of Cryptococcus neoformans with human lung epithelial cells
###end article-title 85
###begin article-title 86
###xml 44 56 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 44 67 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage
###end article-title 86
###begin article-title 87
###xml 55 60 <span type="species:ncbi:9606">human</span>
Binding of glucuronoxylomannan to the CD14 receptor in human A549 alveolar cells induces interleukin-8 production
###end article-title 87
###begin article-title 88
###xml 46 58 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 46 69 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 75 80 <span type="species:ncbi:9606">human</span>
Phospholipase B activity enhances adhesion of Cryptococcus neoformans to a human lung epithelial cell line
###end article-title 88
###begin article-title 89
###xml 27 50 <span type="species:ncbi:5207">cryptococcus neoformans</span>
The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence
###end article-title 89
###begin article-title 90
###xml 48 60 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 48 71 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Recombinational mapping of capsule mutations in Cryptococcus neoformans
###end article-title 90
###begin article-title 91
###xml 12 17 <span type="species:ncbi:9606">human</span>
Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4
###end article-title 91
###begin article-title 92
###xml 53 65 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 53 76 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
###xml 80 85 <span type="species:ncbi:9606">human</span>
Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry
###end article-title 92
###begin article-title 93
Establishment of lipopolysaccharide-dependent nuclear factor kappa B activation in a cell-free system
###end article-title 93
###begin article-title 94
Tumor necrosis factor-mediated cytotoxicity involves ADP-ribosylation
###end article-title 94
###begin article-title 95
Multiple control of interleukin-8 gene expression
###end article-title 95
###begin article-title 96
H2O2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells
###end article-title 96
###begin article-title 97
###xml 23 35 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 23 46 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Serologic evidence for Cryptococcus neoformans infection in early childhood
###end article-title 97
###begin article-title 98
Innate immunity in the lung: how epithelial cells fight against respiratory pathogens
###end article-title 98
###begin article-title 99
Activation of airway epithelial cells by toll-like receptor agonists
###end article-title 99
###begin article-title 100
###xml 31 36 <span type="species:ncbi:9606">human</span>
Neoplastic transformation of a human bronchial epithelial cell line by a recombinant retrovirus encoding viral Harvey ras
###end article-title 100
###begin article-title 101
###xml 68 80 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 68 91 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans
###end article-title 101
###begin article-title 102
###xml 41 53 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 41 64 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Calcineurin is required for virulence of Cryptococcus neoformans
###end article-title 102
###begin article-title 103
###xml 24 36 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 24 47 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structure
###end article-title 103
###begin article-title 104
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 52 64 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 52 75 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents
###end article-title 104
###begin article-title 105
###xml 53 65 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 53 76 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Characterization of a flocculation-like phenotype in Cryptococcus neoformans and its effects on pathogenesis
###end article-title 105
###begin article-title 106
###xml 60 72 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 60 83 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Identification and characterization of an SKN7 homologue in Cryptococcus neoformans
###end article-title 106
###begin article-title 107
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 110 122 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 110 133 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
Chemokine responses and accumulation of inflammatory cells in the lungs of mice infected with highly virulent Cryptococcus neoformans: effects of interleukin-12
###end article-title 107
###begin article-title 108
C/EBP transcription factors in the lung epithelium
###end article-title 108
###begin article-title 109
Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8
###end article-title 109
###begin article-title 110
###xml 0 24 <span type="species:ncbi:1313">Streptococcus pneumoniae</span>
Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleukin-8 promotor
###end article-title 110
###begin article-title 111
###xml 111 128 <span type="species:ncbi:11320">influenza A virus</span>
Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus
###end article-title 111
###begin article-title 112
###xml 74 95 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Interaction of airway epithelial cells (A549) with spores and mycelium of Aspergillus fumigatus
###end article-title 112

